The Finnish stakeholders of the project Clear waters from pharmaceuticals (CWPharma) gather today, 9th of February, in Helsinki to discuss their needs and viewpoints considering the emissions of pharmaceuticals into the environment.
Active pharmaceutical ingredients (APIs) have beneficial effects on human and animal health, but in the environment they are globally considered as an emerging environmental concern. The environmental fate of most pharmaceuticals and their effects on biota are poorly known.
In October 2017 a consortium of 15 organizations from 7 Baltic countries (Denmark, Estonia, Finland, Germany, Latvia, Poland and Sweden) started their work in the project Clear waters from pharmaceuticals (CWPharma). The project focuses on filling the gaps of knowledge that exist on pharmaceuticals in the Baltic Sea. The work is coordinated by the Finnish Environment Institute SYKE.
CWPharma is financed by the Interreg Baltic Sea Region Programme 2014–2020. The project is supported by EU Strategy for Baltic Sea Region Policy Area Hazards as integrated part of the flagship on Pharmaceuticals in the Environment (PIE) – a Baltic Sea Region cooperation platform.